Sally R. Frenkel

Sally R. Frenkel

Auto-generated profile, based on publicly available information

Sally R. Frenkel

Hospital for Joint Diseases, New York, NY 10003, USA

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2004 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
SFSally R. Frenkel
Sally R. Frenkel
PCPaul E. Di Cesare
Paul E. Di Cesare

1 September 1997 in The Journal of Bone and Joint Surgery. British volume
Verified
Journal Article
Closed access
SFSally R. Frenkel
Sally R. Frenkel
BTBrian Toolan
Brian Toolan
DMDavid Menche
David Menche
MPMark I. Pitman
Mark I. Pitman
JPJames M. Pachence
James M. Pachence
We have developed a novel, two-layered, collagen matrix seeded with chondrocytes for repair of articular cartilage. It consists of a dense collagen layer which is in contact with bone and a porous matrix to support the seeded chondrocytes. The matrices were implanted in rabbit femoral trochleas for up to 24 weeks. The control groups received either a matrix without cells or no implant. The best histological repair was seen with cell-seeded implants. The permeability and glycosaminoglycan content of both implant groups were nearly normal, but were significantly less in tissue from empty defects. The type-II collagen content of the seeded implants was normal. For unseeded implants it was 74.3% of the normal and for empty defects only 20%. The current treatments for articular injury often result in a fibrous repair which deteriorates with time. This bilayer implant allowed sustained hyaline-like repair of articular defects during the entire six-month period of observation.

2 February 2010 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
JFJian Q. Feng
Jian Q. Feng
FGFeng‐Jin Guo
Feng‐Jin Guo
BJBai‐Chun Jiang
Bai‐Chun Jiang
YZYan Zhang
Yan Zhang
SFSally Frenkel
Sally Frenkel
CLChuanju Liu
Chuanju Liu
Granulin epithelin precursor (GEP) has been implicated in development, tissue regeneration, tumorigenesis, and inflammation. Herein we report that GEP stimulates chondrocyte differentiation from mesenchymal stem cells in vitro and endochondral ossification ex vivo , and GEP‐knockdown mice display skeleton defects. Similar to bone morphogenic protein (BMP) 2, application of the recombinant GEP accelerates rabbit cartilage repair in vivo. GEP is a key downstream molecule of BMP2, and it is required for BMP2‐mediated chondrocyte differentiation. We also show that GEP activates chondrocyte differentiation through Erk1/2 signaling and that JunB transcription factor is one of key downstream molecules of GEP in chondrocyte differentiation. Collectively, these findings reveal a novel critical role of GEP growth factor in chondrocyte differentiation and the molecular events both in vivo and in vitro. —Feng, J. Q., Guo, F.‐J., Jiang, B.‐C., Zhang, Y., Frenkel, S., Wang, D.‐W., Tang, W., Xie, Y., Liu, C.‐J. Granulin epithelin precursor: a bone morphogenic protein 2‐inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis. FASEB J. 24, 1879–1892 (2010). www.fasebj.org

1 September 2005 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
SFS.R. Frenkel
S.R. Frenkel
GBG. Bradica
G. Bradica
JBJ.H. Brekke
J.H. Brekke
SGS.M. Goldman
S.M. Goldman
KIK. Ieska
K. Ieska
RKR.T. Kronengold
R.T. Kronengold

1 September 2013 in Biomaterials
Verified
Journal Article
Closed access
YZYun-Peng Zhao
Yun-Peng Zhao
QTQing-Yun Tian
Qing-Yun Tian
SFSally Frenkel
Sally Frenkel
CLChuanju Liu
Chuanju Liu

1 October 1997 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
RCR M Clancy
R M Clancy
JRJ Rediske
J Rediske
XTX Tang
X Tang
NNN Nijher
N Nijher
SFS Frenkel
S Frenkel
SAS B Abramson
S B Abramson
Elevated levels of fibronectin (Fn) in articular cartilage have been linked to the progression of both rheumatoid and osteoarthritis. In this study, we examined intracellular events which follow ligation of Fn to its receptor, the integrin alpha5beta1. In addition, we examined the regulatory influence of nitric oxide on these events, since this free radical has been implicated in cartilage degradation. Exposure of chondrocytes to Fn-coated beads resulted in the circumferential clustering of the alpha5beta1 integrin receptor, which was accompanied by the subplasmalemmal assembly of a focal activation complex comprised of F-actin, the tyrosine kinase, focal adhesion kinase (FAK), the ras related G protein rho A, as well as tyrosine-phosphorylated proteins. Treatment with exogenous nitric oxide (NO) or catabolic cytokines which induce nitric oxide synthase blocked the assembly of F-actin, FAK, rho A and tyrosine-phosphorylated proteins while not affecting the total number of beads bound per cell nor the clustering of alpha5beta1 integrin. Use of a cGMP antagonist (Rp-8-Br cGMPS) or cGMP agonist (Sp-cGMPS) either abolished or mimicked the NO effect, respectively. Adherence of chondrocytes to fibronectin enhanced proteoglycan synthesis by twofold (vs. albumin). In addition, basic fibroblast growth factor (FGF) and insulin growth factor (IGF-1) induced proteoglycan synthesis in chondrocytes adherent to Fn but not albumin suggesting a costimulatory signal transduced by alpha5betal and the FGF receptor. Both constitutive and FGF stimulated proteoglycan synthesis were completely inhibited by nitric oxide. These data indicate that the ligation of alpha5beta1 in the chondrocyte induced the intracellular assembly of an activation complex comprised of the cytoplasmic tail of alpha5beta1 integrin, actin, and the signaling molecules rho A and FAK. We show that NO inhibits the assembly of the intracellular activation complex and the synthesis of proteoglycans, but has no effect on the extracellular aggregation of alpha5beta1 integrin. These observations provide a basis by which nitric oxide can interfere with chondrocyte functions by affecting chondrocyte-matrix interactions.